Test Predicts Which Patients with Prostate Cancer Are Most Likely to Develop Long-Term Side Effects From Radiation Therapy
The test, called PROSTOX, is the first of its kind to use microRNAs to predict toxicity from cancer therapy. It could help prevent the burden of long-term complications by identifying patients most at risk before treatment even begins.
7-Apr-2025 11:20 AM EDT
Add to Favorites